$2.7B Salix Inversion 1st Casualty Of Government Crackdown
Rules introduced last month to curb tax benefits tied to cross-border mergers claimed their first casualty on Friday, when Salix Pharmaceuticals Ltd. scrapped its $2.7 billion plan to unite with the...To view the full article, register now.
Already a subscriber? Click here to view full article